Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating a quadruple combination therapy (fruquintinib, nab-paclitaxel, iparomlimab, and tuvonralimab) for second…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer
This clinical trial investigates how patient age influences treatment choices and prognosis in resectable gastric cancer, incorporating next…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
A Phase III trial evaluating SHR-A1811 with chemotherapy and Adebrelimab in untreated, unresectable or metastatic gastric or gastroesophagea…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma [Phase 3]
A Phase III clinical trial is evaluating Cadonilimab in combination with the SOX chemotherapy regimen as perioperative treatment for patient…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
A clinical trial from Fudan University is evaluating whether adding a PD-1 monoclonal antibody to chemotherapy improves outcomes in metastat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy [Phase 2]
A Phase 2 trial evaluating first-line dual immunotherapy plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma; the stud…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
This clinical trial update describes a study using multimodal artificial intelligence to predict response to neoadjuvant immunotherapy in ga…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CONFIRM: Magnetic Resonance Guided Radiation Therapy [NA]
ClinicalTrials.gov study CONFIRM is evaluating magnetic resonance guided radiation therapy and is currently recruiting for several cancers, …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer [Phase 2]
Phase 2 trial evaluating neratinib in combination with chemotherapy, trastuzumab, and pembrolizumab for HER2-positive gastroesophageal cance…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer [EARLY_Phase 1]
An early-phase study evaluating CBG131 CAR-T cell therapy targeting CLDN18.2 for advanced gastric and pancreatic cancer. The trial is not ye…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Validation of AI-ENDO System in Endoscopic Submucosal Dissection [NA]
A clinical trial is validating the AI-ENDO System for use during endoscopic submucosal dissection of superficial lesions in the esophagus, s…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. [Phase 3]
LM-302 is being evaluated in a Phase 3 trial for Claudin18.2-positive gastric and gastroesophageal junction adenocarcinoma; the study is cur…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of SH009 Injection in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 clinical trial update for SH009 Injection in patients with advanced solid tumors, currently recruiting across multiple indications…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma
This clinical trial update reports ongoing recruitment for second-line regimens based on albumin-bound paclitaxel to treat locally advanced …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: CTNNA1 Familial Expansion Study
The CTNNA1 Familial Expansion Study is currently recruiting to investigate CTNNA1 gene mutations in gastric cancer and related cancers, incl…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients [Phase 2]
Phase 2 clinical trial evaluating zanidatamab in combination with pembrolizumab and chemotherapy as first-line therapy for metastatic gastro…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
This multicenter clinical trial compares minimally invasive proximal gastrectomy with total gastrectomy for proximal gastric and gastroesoph…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
This update describes the Moonshot Study's genetic analysis of blood and tissue samples from patients with advanced cancer; the study status…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis [Phase 2]
This Phase 2 clinical trial assesses sequential systemic therapy followed by intraperitoneal paclitaxel for gastric cancer with peritoneal c…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer
A clinical trial is investigating biomarkers of risk for pre-neoplastic and neoplastic gastric lesions to inform the development of gastric …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study Collecting Health Information to Understand and Prevent Gastric Cancer
This recruiting clinical trial, sponsored by Memorial Sloan Kettering Cancer Center, seeks to collect health information to understand and p…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III [Phase 3]
This ClinicalTrials.gov entry describes the Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial (Stage III), a Phase 3 study …
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy [Phase 1, Phase 2]
A Phase 1/2 trial of CHM-2101, an autologous CDH17 CAR-T therapy, is evaluating safety and early efficacy in neuroendocrine tumors, colorect…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase Ib/II study of TCC1727 in combination therapy for advanced solid tumors, including non-small cell…